Search

for
Search:

Research

5 / 1000+ results

research 5α-Reductase Inhibitors, Chemical and Clinical Models

17 citations , May 1998 in “Steroids”

This study constructed a model to predict finasteride's inhibitory activity on 5α-reductase type 2 and calculated that a 1 μM plasma concentration, after 50 mg administration, matches prostate inhibition levels.

research Novel inhibitors of 5α-reductase

20 citations , February 2002 in “Expert Opinion on Therapeutic Patents”

This review discusses the potential uses of 5α-reductase inhibitors for conditions ranging from benign prostatic hyperplasia to skin disorders like acne and male pattern baldness, but it reports no new clinical results.

Synthesis and In Vitro Study of 17β-[N-Ureylene-N,N′-Disubstituted]-4-Methyl-4-Aza-5α-Androstan-3-Ones as Selective Inhibitors of Type I 5α-Reductase

research Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase

5 citations , February 1997 in “Bioorganic & Medicinal Chemistry”

This study found that among 17 beta-(N-ureylene-N,N'-disubstituted)-4-azasteroids, those with an N'-phenyl moiety were the most effective inhibitors of human type I 5 alpha-reductase.

research Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases

11 citations , February 2016 in “Current Medicinal Chemistry”

This review discusses various targets for treating prostate cancer and benign prostatic hyperplasia and reports on recent studies of new compounds and 5α-reductase inhibitors, but provides no new experimental results.

research Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics

December 2022 in “Scientific Reports”

This study found that caffeic acid amide derivative, compound 4, effectively inhibited steroid 5α-reductase type 1 in vitro, suggesting potential for development as a treatment for androgenic alopecia.

View more "19-nor-10-azasteroid" in research →

Community Join

5 / 1000+ results

community 18-19, 10 months of fin progress @ 0.5mg daily

in Progress Pictures 18 upvotes 1 month ago

The conversation discusses hair loss treatment progress using finasteride at 0.5mg daily over 10 months. The user reports noticeable progress, particularly after 4 months, with a buzz cut showing the results.

community 10 Months progress finasteride

in Progress Pictures 6 upvotes 5 months ago

A 19-year-old male shared his 10-month progress using finasteride, starting at 0.25mg and increasing to 1.25mg daily, noting new hair growth at the temples. He experienced a significant shed at 6 months but reported no side effects from increasing the dosage.

community 10 months on oral fin and my hair keeps on getting worse

in Finasteride/Dutasteride 21 upvotes 2 years ago

A 19-year-old male has seen no improvement in hair loss after 10 months on oral finasteride and 2 years on topical minoxidil, with hair thinning and a receding hairline continuing. One reply suggests getting tests to confirm if DHT is the cause of the hair loss.

community My hairloss 26m on fin microdosing and min tretinoin

1 upvotes 5 months ago

A 26-year-old discusses hair loss treatment using oral finasteride microdosing, topical minoxidil with tretinoin, and dermastamping every 10 days. They started experiencing hair loss at 19 and have been using these treatments for 8 months.

community 10% minoxidil is good to start with?

in Basic Questions 82 upvotes 3 weeks ago

A 35-year-old experiencing hair loss since age 20 is considering starting Minoxidil treatment. They are unsure whether to begin with 10% Minoxidil or start with 5% and increase later.

View more "19-nor-10-azasteroid" in community →

Clinics

6 / 11 results

All 11 clinic results →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →